Anticholinergic agents for the treatment of ''death rattle'' in patients with myasthenia gravis

Publisher： Elsevier

ISSN： 0885-3924

Source： Journal of Pain and Symptom Management, Vol.26, Iss.1, 2003-07, pp. : 684-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA Class II and class I polymorphism in venezuelan patients with myasthenia gravis

By Fernandez-Mestre M.T. Vargas V. Montagnani S. Cotua M. Ogando V. Layrisse Z.

Human Immunology, Vol. 65, Iss. 1, 2004-01 ,pp. : 54-59

Elsevier

Access to resources Recommend Favorite

Specific Removal of Anti-acetylcholine Receptor Antibodies in Patients with Myasthenia Gravis

By Takamori M. Ide Y.

Transfusion and Apheresis Science, Vol. 17, Iss. 3, 1996-09 ,pp. : 445-453

Elsevier

Access to resources Recommend Favorite

TCR-Vβ Usage in the Thymus and Blood of Myasthenia Gravis Patients

By Navaneetham D. Penn A.S. Howard J.F. Conti-Fine B.M.

Journal of Autoimmunity, Vol. 11, Iss. 6, 1998-12 ,pp. : 621-633

Academic Press

Access to resources Recommend Favorite

Specific Removal of Anti-acetylcholine Receptor Antibodies in Patients with Myasthenia Gravis

By Takamori M. Ide Y.

Transfusion Science, Vol. 17, Iss. 3, 1996-09 ,pp. : 445-453

Elsevier

Access to resources Recommend Favorite

Plasmapheresis in Myasthenia Gravis.

By Kuks J.B.M. Skallebaek D.

Transfusion and Apheresis Science, Vol. 19, Iss. 2, 1998-06 ,pp. : 129-136

Elsevier

Access to resources Recommend Favorite